Scientists are making the case that a vaccine against rhinoviruses, the predominant cause of the common cold, is achievable.
The quest for a vaccine against rhinoviruses may have seemed quixotic, because there are more than 100 varieties circulating around the world. Even so, the immune system can handle the challenge, researchers from Emory University School of Medicine and Children’s Healthcare of Atlanta say.
Vaccines that combine dozens of varieties of rhinovirus at once are effective in stimulating antiviral antibodies in mice and monkeys, the researchers report in Nature Communications. The paper was also posted on Biorxiv before publication.
“We think that creating a vaccine for the common cold can be reduced to technical challenges related to manufacturing,” says Martin Moore, PhD, associate professor of pediatrics at Emory University School of Medicine.
Rhinoviruses are the most common cause of the common cold; other viruses such as respiratory syncytial virus, parainfluenza virus and adenoviruses can cause them too. Rhinoviruses also exacerbate asthma attacks. Although they come in many varieties, rhinoviruses do not drift to the same degree that influenza viruses do, Moore says.
Researchers showed in the 1960s that it was possible to vaccinate people against one variety of rhinovirus and prevent them from getting sick when challenged with samples of the same virus. The trouble was the sheer diversity of rhinoviruses – or that’s how it appeared at the time.
“It’s surprising that nobody tried such a simple solution over the last 50 years. We just took 50 types of rhinovirus and mixed them together into our vaccine, and made sure we had enough of each one,” Moore says. “If we make a vaccine with 50 or 100 variants, it’s the same amount of total protein in a single dose of vaccine. The variants are like a bunch of slightly different Christmas ornaments, not really like 50 totally different vaccines mixed.”
A mixture of 25 types of inactivated rhinovirus can stimulate neutralizing antibodies against all 25 in mice, and a mixture of 50 types can do the same thing in rhesus macaques. In this paper, antibodies generated in response to the vaccine were tested for their ability to prevent the virus from infecting human cells in culture. However, the vaccines were not tested for their ability to stop animals from getting sick.
“There are no good animal models of rhinovirus replication,” Moore says. “The next step would be human challenge models with volunteers, which are feasible because the virus is not very pathogenic.”
Emory has optioned the vaccine technology to a startup company, Meissa Vaccines, Inc., which is pursuing a product development plan with support from the National Institute of Allergy and Infectious Diseases’ vaccine manufacturing services.
Learn more: Vaccine vs many common cold viruses achievable
The Latest on: Vaccine against rhinoviruses
via Google News
The Latest on: Vaccine against rhinoviruses
- Polio Virus Structure Revealed : Scripps Team's Discovery May Lead to Safer Vaccineon April 13, 2019 at 4:09 am
as the present vaccines do. Researchers at Purdue University announced last week that they had deciphered the molecular structure of a common cold virus, known as rhinovirus-14, which could help in ... […]
- A Novel Substituted Guanidine with High Activity in vitro against Rhinoviruseson March 7, 2019 at 12:30 am
THE number and diversity of the viruses which infect the upper respiratory tract, and cause the common cold, virtually preclude the control of this disease by conventional vaccines ... activity in ... […]
- Rhinovirus Infection Drug Pipeline Study, H2 2018 - Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugson January 28, 2019 at 8:35 am
The Rhinovirus Infection pipeline guide presents complete ... Fourteen companies are currently developing vaccines and treatment options against tetanus infections. The companies in global tetanus ... […]
- Flu jab: Can it prevent the common cold? Contents of this year’s vaccine revealedon September 29, 2018 at 11:00 pm
“Flu vaccines do not protect against other influenza strains not included in the vaccine and have no effect against the rhinoviruses and other types of virus that cause common cold symptoms,” said Dr ... […]
- Surprisingly simple common cold vaccine may defend against many strainson September 28, 2018 at 5:00 pm
Now, a team at Emory University has used a surprisingly simple technique, mixing multiple types of rhinovirus into one vaccine, and found it stimulated the immune system against all of the included ... […]
- Common cold vaccine may be more than a dreamon September 25, 2018 at 5:00 pm
A vaccine against rhinoviruses, the predominant cause of the common cold, is achievable, scientists say. The quest for a vaccine against rhinoviruses may have seemed quixotic, as there are more than ... […]
- Vaccines Against a Vanishing Virus?on September 25, 2018 at 5:53 am
If you’re going to prove that a Zika vaccine works, a human challenge may be the only way. Doing that with rhinovirus is considered completely acceptable, while doing that with (say) Ebola is ... […]
- Why Haven't We Cured the Common Cold Yet?on September 8, 2018 at 10:51 am
says virologist Martin Moore of Meissa Vaccines, a company currently developing an inoculation against rhinovirus. “You’ve got this great number of serotypes that circulate all the time, and that ... […]
- Chip identifies rhinoviruses as a cause of asthma : Studyon June 18, 2018 at 7:34 am
This paves the way for developing a new vaccine which should protect against these particularly dangerous viruses. Certain rhinoviruses are responsible for up to 80% of all asthma attacks. Viral ... […]
via Bing News